利用组织特定的增强剂-向基因调控网络,识别了增强剂体质突变,这些突变对肺癌有功能影响
Judith Mary Hariprakash1, Elisa Salviato1, Federica La Mastra1
1IFOM-ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.
Cancer research
|October 19, 2023
概括
这项研究确定并描述了肺癌亚型中非编码调节性DNA增强剂的体质突变. 这些增强子突变影响基因表达和生物通路,对瘤发育和患者预后至关重要.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 增强剂是调节基因转录的非编码DNA区域,通常在很长的距离上.
- 增强剂的变化与包括癌症在内的各种疾病有关,但识别功能突变是具有挑战性的.
- 非编码调节区域的体质突变与瘤发生和预后有关.
研究的目的:
- 开发一种用于检测和表征肺癌中增强器突变的策略.
- 分析这些突变对基因表达和生物通路的功能影响.
- 探索增强器突变对于患者分类的潜力.
主要方法:
- 在三种肺癌亚型中对患者队列进行全基因组分析.
- 使用实验和表观遗传学数据定义肺组织特异性增强剂.
- 构建增强剂向基因调控网络,整合3D染色体架构.
- 基于途径级整合和频率的功能相关突变的优先级.
主要成果:
- 肺癌在增强剂和外子中表现出类似的突变负担,但具有不同的突变特征.
- 突变增强剂汇聚在关键的生物过程和与瘤生物学相关的途径上.
- 经常出现的增强器突变会改变基因表达,影响患者的预后.
结论:
- 增强剂中的非编码调控突变在癌症发病过程中起着重要作用.
- 这些发现突显了增强器突变对于理解癌症发展和患者分类的潜力.
更多相关视频
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.2K
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.6K
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
